The promising results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had no measurable disease at the end of the trial, the researchers added.
Their results are scheduled to be presented Saturday at the American Association for Cancer Research's annual meeting in Washington, D.C.
Ovarian cancer is fairly rare -- an estimated 1.38 percent of females born today will be diagnosed with the condition -- but it's an especially deadly form of cancer because it is usually diagnosed in an advanced stage.
The new treatment uses a personalized vaccine to try to teach the body's immune system how to fight off tumors.
The internet was outraged earlier this month after a new report revealed the sugar industry paid...
- Zika, dengue, chikungunya: As if there weren't enough mosquito-borne viruses to worry about, researchers say...
Gonorrhea appears to be developing resistance to the two antibiotics that constitute the last available treatment...
Even with drastic decreases in the number of Americans who smoke, four out of ten children...
